For citations:
Krysanov I.S., Makarova E.V., Ermakova V.Yu. CLINICAL AND ECONOMIC EVALUATION OF ATEZOLIZUMAB + VEMURAFENIB + COBIMETINIB COMBINATION AND NIVOLUMAB + IPILIMUMAB COMBINATION: ADMINISTRATION IN METASTATIC MELANOMA TREATMENT WITH BRAF-CONFIRMED MUTATION IN ADULT PATIENTS. Pharmacy & Pharmacology. 2022;10(3):278-288. https://doi.org/10.19163/2307-9266-2022-10-3-278-288